GCP Refresher

Current Status
Not Enrolled
Get Started

Download Course Summary Leaflet

GCP Refresher Online Course

This professionally developed, interactive, and engaging online GCP training course incorporates the ICH GCP E6 R2 guidance and the EU Clinical Trials Regulation which became live on the 31st January 2022.

This GCP refresher training is suitable for anyone carrying out or involved in clinical research who has already taken full GCP training and needs a refresh in the main concepts and principles of GCP.

The GCP refresher course was created by our subject matter expert who has worked in clinical research for over 30 years and has delivered training in GCP all around the world. The course meets the required standards for ICH GCP Investigator site personnel training, identified by Transcelerate Biopharma Inc. (this can be checked on their website).

*This is the new updated course of GCP refresher training for 2022. This most recent update ensures content remains current and includes improved knowledge checks and interaction to create a more engaging experience for our users.

You will also gain free access to our online course – “Managing Clinical Trials During COVID-19”.


Learning Objectives in the GCP Refresher Training

  • Understand what GCP is, why it is necessary, and its practical implications
  • Examine key legislation surrounding GCP
  • Learn the responsibilities of the key stakeholders in a Clinical Trial and how these relate to GCP
  • Develop extensive knowledge and understanding of GCP to ensure compliance
  • Understand the importance of key documents relating to Clinical Trials including the protocol, Investigator’s Brochure and Essential Documents
  • Learn how to assess GCP compliance and understand how to effectively tackle under-performance


Course Support

When the course module opens in a new window, ensure all ticks down the sidebar of the page appear blue like the image below before closing the window.

The course won't progress to the next module unless all ticks are blue.